These findings establish a regulatory link between inflammatory signaling and adipocyte metabolism and suggest that the IL18 signaling from NCC and IL18r in different adipose tissues (Fig. 10) represents distinct therapeutic approaches to protect against thermogenesis-defect-associated energy expenditure and obesity and insulin signaling defect-associated diabetes. The gene discussed is IL18R1; the disease is obesity due to melanocortin 4 receptor deficiency.